FGF19 and neoplasm: Together, we discovered what we believe is a previously undescribed paradigm whereby tumor cells collaborate via HMGA1 and FGF19 to drive progression, thus illuminating FGF19 as a rational therapeutic target for a molecular subclass composed of the most aggressive human PDACs.